Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MAP3K20
   Synonyms MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK
   Region GRCh38_2:173075435-173268010    Sequence
   Ensembl ENSG00000091436
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name gastric cancer
   ICD-0-3 C16  
   Methods qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP etc.
   Sample cell line (HGC27, SGC7901, MGC803, AGS and MKN-45, GES-1), gastric cancer tissues
   Expression Pattern up-regulated
   Function Description

MLK7-AS1 interacted with Dnmt1 and recruited it to miR-375 promotor, hyper-methylating miR-375 promotor and repressing miR-375 expression. Our findings demonstrate that knockdown of MLK7-AS1 by siRNA inhibits gastric cancer growth by epigenetically regulating miR-375. Knockdown of MLK7-AS1 by siRNA increased the expression of miR-375. MiR-375 wasfound to be an important tumor suppressor in gastric cancer bytargeting Janus kinase 2 (JAK2).

   Pubmed ID 29428732
   Year 2018
   Title Knockdown of long non-coding RNA MAP3K20 antisense RNA 1 inhibits gastric cancer growth through epigenetically regulating miR-375.
   External Links
   Links for  MAP3K20 GenBank       HGNC       lncrnadb       Noncode
   Links for  gastric cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.